141 related articles for article (PubMed ID: 736209)
1. Proliferative serous tumors of the ovary. Histologic features and prognosis.
Katzenstein AL; Mazur MT; Morgan TE; Kao MS
Am J Surg Pathol; 1978 Dec; 2(4):339-55. PubMed ID: 736209
[TBL] [Abstract][Full Text] [Related]
2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
3. Periodic acid-Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors.
Aalto ML; Collan Y
Int J Gynaecol Obstet; 1986 Feb; 24(1):27-34. PubMed ID: 2874066
[TBL] [Abstract][Full Text] [Related]
4. Frequency of papillary tubal hyperplasia (PTH), salpingoliths and transition from adenoma to borderline ovarian tumors (BOT): A systematic analysis of 74 BOT with different histologic types.
Horn LC; Angermann K; Hentschel B; Einenkel J; Höhn AK
Pathol Res Pract; 2017 Apr; 213(4):305-309. PubMed ID: 28238382
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
Devaney K; Goodman ZD; Ishak KG
Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
[TBL] [Abstract][Full Text] [Related]
6. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
Hart WR
Hum Pathol; 1977 Sep; 8(5):541-9. PubMed ID: 903145
[TBL] [Abstract][Full Text] [Related]
7. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
Ahn G; Folkins AK; McKenney JK; Longacre TA
Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.
Griffiths AP; Cross D; Kingston RE; Harkin P; Wells M; Quirke P
Int J Gynecol Pathol; 1993 Oct; 12(4):307-14. PubMed ID: 8253547
[TBL] [Abstract][Full Text] [Related]
9. On the histogenesis and morphology of ovarian carcinomas.
Dallenbach-Hellweg G
J Cancer Res Clin Oncol; 1984; 107(2):71-80. PubMed ID: 6715398
[TBL] [Abstract][Full Text] [Related]
10. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
Scully RE
Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
[TBL] [Abstract][Full Text] [Related]
11. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
Dehari R; Kurman RJ; Logani S; Shih IeM
Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
Riopel MA; Ronnett BM; Kurman RJ
Am J Surg Pathol; 1999 Jun; 23(6):617-35. PubMed ID: 10366144
[TBL] [Abstract][Full Text] [Related]
13. Cystic neoplasms of the pancreas.
Yamaguchi K; Enjoji M
Gastroenterology; 1987 Jun; 92(6):1934-43. PubMed ID: 3471621
[TBL] [Abstract][Full Text] [Related]
14. Histologic sampling requirements in ovarian carcinoma: a review of 51 tumors.
Gramlich T; Austin RM; Lutz M
Gynecol Oncol; 1990 Aug; 38(2):249-56. PubMed ID: 2167283
[TBL] [Abstract][Full Text] [Related]
15. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
[TBL] [Abstract][Full Text] [Related]
16. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
17. 72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and Serological study.
De Nictolis M; Garbisa S; Lucarini G; Goteri G; Masiero L; Ciavattini A; Garzetti GG; Stetler-Stevenson WG; Fabris G; Biagini G; Prat J
Int J Gynecol Pathol; 1996 Apr; 15(2):102-9. PubMed ID: 8786198
[TBL] [Abstract][Full Text] [Related]
18. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cystadenoma and cystadenocarcinoma.
von Segesser L; Rohner A
Br J Surg; 1984 Jun; 71(6):449-51. PubMed ID: 6722483
[TBL] [Abstract][Full Text] [Related]
20. [Pitfalls and common problems in the differential diagnosis of epithelial ovarian tumors].
Lax SF
Pathologe; 2019 Feb; 40(1):46-60. PubMed ID: 30719693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]